According to DBV Technologies's latest financial reports the company's current earnings (TTM) are -$72.72 M. an increase over its 2022 earnings that were of -$96.21 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$72.72 M | -24.41% |
2022 | -$96.21 M | -2.02% |
2021 | -$98.19 M | -38.47% |
2020 | -$0.16 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Ionis Pharmaceuticals
IONS | -$0.26 B | 255.29% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | -$79.39 M | 9.17% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$0.2 B | 171.21% | ๐บ๐ธ USA |